Knowledge Center

Patent / Jan 01, 1973

21-Sulfuric acid or 21-orthophosphoric acid ester sodium salts of prednisolone or 9.alpha.-fluoro-16.beta.-methylprednisolone

Authors:

Ivan Villax

Source:

DE 1793707

Prednisolone esters I [R = (HO)2PO, (HO)SO2; R1 = H, Me; R2 = H, F]. (4 compds.) were prepd. Thus, prednisolone (I; R = R1 = R2 = H) was treated with EtO2COCl-H3PO4 in Et3N-MeCN and then with NaOMe to give 66% I [R = (HO)2PO].

Also in the Knowledge Center

/ Oct 05, 2023

Inhalable pharmaceutical composition containing spray dried cohesive composite active particles and carrier based formulation combination

Scientific Article

View

/ Nov 30, 2023

Webinar - Nasal powder delivery: Process, formulation and analytical characterization

Scientific Article

View

/ Dec 24, 2020

Continuous process for the preparation of anticholinergic drugs

Scientific Article

View

Browser not supported

Knowledge Center

21-Sulfuric acid or 21-orthophosphoric acid ester sodium salts of prednisolone or 9.alpha.-fluoro-16.beta.-methylprednisolone

Also in the Knowledge Center

Inhalable pharmaceutical composition containing spray dried cohesive composite active particles and carrier based formulation combination

Webinar - Nasal powder delivery: Process, formulation and analytical characterization

Continuous process for the preparation of anticholinergic drugs

Related Content

Cryogenics

Our Policies

Hovione partners with Dragonfly Technologies to offer micellar chemistry technology to customers as a sustainable alternative to conventional chemical processes